| |
| What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation |
| Leaviss J, Sullivan W, Ren S, Everson-Hock E, Stevenson M, Stevens JW, Strong M, Cantrell A |
|
|
| |
Record Status This is a systematic review that meets the criteria for inclusion on DARE. Bibliographic details Leaviss J, Sullivan W, Ren S, Everson-Hock E, Stevenson M, Stevens JW, Strong M, Cantrell A. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation. Health Technology Assessment 2014; 18(33): 1-119 Indexing Status Subject indexing assigned by NLM MeSH Adult; Aged; Alkaloids /adverse effects /economics /therapeutic use; Azocines /adverse effects /economics /therapeutic use; Benzazepines /adverse effects /economics /therapeutic use; Cost-Benefit Analysis; Great Britain; Humans; Middle Aged; Nicotinic Agonists /adverse effects /economics /therapeutic use; Quality-Adjusted Life Years; Quinolizines /adverse effects /economics /therapeutic use; Quinoxalines /adverse effects /economics /therapeutic use; Randomized Controlled Trials as Topic; Smoking /economics; Smoking Cessation /economics /methods; State Medicine; Varenicline AccessionNumber 12014031875 Date bibliographic record published 23/05/2014 |
| |
|
|
